SCHEMBL2805149

SCHEMBL2805149

CN1CCN(CCCNc2ncc3c(n2)-c2ccccc2C(c2ccc(Cl)cc2)C3)CC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 20/20 0.48
EGFR P00533 5/20 0.47
SRC P12931 4/20 0.47
FGFR2 P21802 4/20 0.47
FGFR4 P22455 3/20 0.47
FGFR3 P22607 3/20 0.47
PRKD3 O94806 1/20 0.42
PRKCG P05129 1/20 0.42
PRKCB P05771 1/20 0.42
PRKCA P17252 1/20 0.42
PRKCH P24723 1/20 0.42
PRKCI P41743 1/20 0.42
PRKCE Q02156 1/20 0.42
PRKCQ Q04759 1/20 0.42
PRKCZ Q05513 1/20 0.42
PRKCD Q05655 1/20 0.42
PRKD1 Q15139 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803937 0.94 FGFR1 (0.45) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2807786 0.93 FGFR1 (0.47) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2806396 0.93 FGFR1 (0.53) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2804561 0.91 FGFR1 (0.47) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2486812 0.91 FGFR1 (0.49) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2803188 0.91 FGFR1 (0.44) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2804139 0.90 FGFR1 (0.50) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2804174 0.90 FGFR1 (0.50) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2486950 0.90 FGFR1 (0.50) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL2807020 0.89 FGFR1 (0.54) FGFR1EGFRSRCFGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885EGFR 1297/4885SRC 642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.